您的位置: 首页 > 农业专利 > 详情页

COMPOSITIONS PHARMACEUTIQUES POUR LE TRAITEMENT DE TUMEURS QUI EXPRIMENT LE REGF ET GANGLIOSIDE N-GLYCOLYL GM3 (NEUGCGM3
专利权人:
Centro de Inmunologia Molecular
发明人:
申请号:
EP12806334.4
公开号:
EP2805747A1
申请日:
2012.12.04
申请国别(地区):
EP
年份:
2014
代理人:
摘要:
The present invention relates to pharmaceutical compositions for the treatment of malignant tumors. Particularly those tumors that express EGFR and GM3 N-glycolyl ganglioside targets to enhance the therapeutic effect produced by separated therapies against these targets. The pharmaceutical compositions of the invention include antibodies and/or vaccines against each of the targets. Additionally the present invention relates to methods for applying the compositions of the invention.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充